Skip to main content
. 2023 May 8;12(9):3336. doi: 10.3390/jcm12093336

Table 3.

Effect of tobacco smoking on the development of hepatocellular carcinoma.

Group Non-Smoker Ex-Smoker Current Smoker
Total Total, no. 175,678 53,584 53,826
Events, no. 1519 670 714
Person-years 873,465 265,865 266,901
Adjusted * HR 1 (ref) 1.11 (1.00–1.24) 1.21 (1.09–1.35)
MAFLD Total, no. 52,159 29,050 29,654
Events, no. 745 451 527
Person-years 258,616 144,007 146,767
Adjusted * HR 1 (ref) 1.04 (0.91–1.19) 1.24 (1.08–1.41)
Control Total, no. 123,519 24,534 24,172
Events, no. 774 219 187
Person-years 614,849 121,858 120,134
Adjusted * HR 1 (ref) 1.18 (0.99–1.42) 1.07 (0.89–1.30)
Subgroup: liver cirrhosis Total, no. 166 126 156
Events, no. 17 11 17
Person-years 792 597 720
Adjusted * HR 1 (ref) 0.89 (0.40–1.99) 1.25 (0.59–2.64)

Abbreviations: no., number; HR, hazard ratio. * Adjusted for age, sex, alcohol drinking, exercise, body mass index, diabetes, hypertension, dyslipidemia, and presence of cirrhosis.